Organon (NYSE: OGN) reported Q4 EPS of $0.81, $0.11 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.49 billion.

For earnings history and earnings-related data on Organon (OGN) click here.